PillRx only · Powder, For Suspension · Oral
Cefprozil
Cefprozil
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.166
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
5
Active US suppliers
54%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
19K
Rx · 2026 Q1
2.1M
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Lupin Pharmaceuticals,Inc. | unknown | 7 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 6 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 6 | SUPPLYING |
| NorthStar Rx LLC | unknown | 4 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 26, 2021RECALLRecall (Class II): Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (w…
Superpotent Drug — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA and Puerto Rico